This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Long-Term Efficacy of Dupilumab in Quadrants of Elevated- vs Low- Type 2 Biomarker Patients With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA TRAVERSE, Journal of Allergy and Clinical Immunology, February 2022, Elsevier,
DOI: 10.1016/j.jaci.2021.12.625.
You can read the full text:
The following have contributed to this page
PLoS Pathogens
Streptococcus pneumoniae (pneumococcus), harmlessly resides in human nasopharynx, but at times turn pathogenic and invade sterile body compartments resulting in fatal diseases such as pneumonia and...
Developmental & Comparative Immunology
From the dromedary camel and all five living camelids, we have identified a novel type of mammalian interferon beta with four cysteine residues. Camelid IFN-β is unique with an even number of cyste...
Ocular Immunology and Inflammation
We described a newer strategy to quantify the health of Choriocapillaris in Normal eyes and those recovered from inflammation of Retina
